More Articles

Optibiotix discusses 'critical' couple of years

Optibiotix discusses 'critical' couple of years

The next 24-36 months will be crucial for this life sciences minnow, as it nears product commercialisation, its boss tells David Brenchley.

Carpetright rally meets sticky end

Carpetright rally meets sticky end

Admitting it didn't make as much last year as many thought, Carpetright shares have plunged. Lee Wild analyses the chances of a swift recovery.

11 shares to beat record-breaking FTSE 250

11 shares to beat record-breaking FTSE 250

This portfolio has smashed the mid-cap index since inception in December, writes David Brenchley, and new shares are already making an impact.

Tactical Asset Allocator: Is this a sign markets are about to topple?

Tactical Asset Allocator: Is this a sign markets are about to topple?

Is this exchange traded fund (ETF) launch a sign that financial markets are ripe for a fall? Ceri Jones investigates.

The Oil Man: Oil price, Sound Energy, SDX Energy, Savannah Petroleum

The Oil Man: Oil price, Sound Energy, SDX Energy, Savannah Petroleum

Oil industry analyst Malcolm Graham-Wood has seen it all. He gives Interactive Investor his opinion on the sector's top stories.

Barclays' path to 300p-plus

Barclays' path to 300p-plus

It is absolutely critical that Barclays' share price close above this price sometime soon, argues chartist Alistair Strang. Do it, and we're one step nearer the 'action area'.

Stockwatch: A potential multi-bagger

Stockwatch: A potential multi-bagger

Narcissism is a big money-spinner for this small-cap company, which Edmond Jackson believes has the potential to grow fast.

French inject UK equities with va-va-voom

French inject UK equities with va-va-voom

With the French far-right now even less likely to force a break-up of the EU, Lee Wild assesses market reaction and what happens next.

Lok'nStore tipped to eliminate big discount to peers

Lok'nStore tipped to eliminate big discount to peers

Healthy cash generation and a 'robust' balance sheet is helping Lok'nStore grow as shareholders sit on big gains, writes David Brenchley.

Chart of the week: Great area to buy this FTSE 100 bank

Chart of the week: Great area to buy this FTSE 100 bank

Technical analyst John Burford may have identified another tradeable point for the FTSE 100, and the best place to buy a heavyweight bank's shares.

The 10 shares owned by 70% of UK equity income funds

The 10 shares owned by 70% of UK equity income funds

More than a quarter of the money managed by UK equity income funds is invested in just 10 dividend-paying companies. Moira O'Neill names them here.

The Oil Man: Oil price, Aminex, Genel, Lamprell

The Oil Man: Oil price, Aminex, Genel, Lamprell

Oil industry analyst Malcolm Graham-Wood has seen it all. He gives Interactive Investor his opinion on the sector's top stories.

FTSE 100: Where growth to 7,430 is 'again believable'

FTSE 100: Where growth to 7,430 is 'again believable'

There are plenty of drop targets for the FTSE 100, says chartist Alistair Strang, but we're not in lemming territory just yet.

The week ahead: Lloyds Bank, Barclays, Standard Chartered

The week ahead: Lloyds Bank, Barclays, Standard Chartered

It's a bumper week for banks who report first-quarter results, but what are their prospects?

42 ways you could have doubled your money in 2017

42 ways you could have doubled your money in 2017

The FTSE 100 may be in negative territory for 2017, but higher-risk investors could have made a killing this year. David Brenchley reveals how.

Portmeirion in three-way scrap for place on this 'buy list'

 Portmeirion in three-way scrap for place on this 'buy list'

There's plenty to encourage long-term investors to hold Portmeirion shares through thick and thin, but will companies analyst Richard Beddard add them to his portfolio?

Boom time at M&S?

Boom time at M&S?

After trading sideways since the EU referendum, M&S shares have just taken off and hit a 10-month high. David Brenchley explains why.

Insider: A little-known AIM share worth watching

Insider: A little-known AIM share worth watching

There's strong momentum at this £80 million growth play and bosses keep buying, writes Lee Wild. But is selling at a recent favourite cause for concern?

Neil Woodford asks for patience after performance disappoints

Neil Woodford asks for patience after performance disappoints

Woodford Patient Capital reported a fall in net asset value of 4.2% for 2016, whichmeans investors will not pay a performance fee. Kyle Caldwell explains.

The Oil Man: Oil price, Amerisur, Ithaca Energy

The Oil Man: Oil price, Amerisur, Ithaca Energy

Oil industry analyst Malcolm Graham-Wood has seen it all. He gives Interactive Investor his opinion on the sector's top stories.